Form 10-KT/A - Transition reports [Rule 13a-10 or 15d-10]: [Amend]
SEC Accession No. 0001140361-14-020175
Filing Date
2014-05-12
Accepted
2014-05-12 16:20:55
Documents
13
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 RAPTOR PHARMACEUTICALS CORP 10-KT A NO 2 12-31-2012 form10kta2.htm 10-KT/A 3602142
2 EXHIBIT 23.1 ex23_1.htm EX-23.1 2675
3 EXHIBIT 23.2 ex23_2.htm EX-23.2 3130
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 8013
5 EXHIBIT 31.2 ex31_2.htm EX-31.2 7721
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 7955
13 image0.jpg GRAPHIC 37248
  Complete submission text file 0001140361-14-020175.txt   15725394

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rptp-20121231.xml EX-101.INS 2289897
8 XBRL TAXONOMY EXTENSION SCHEMA rptp-20121231.xsd EX-101.SCH 105074
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rptp-20121231_cal.xml EX-101.CAL 99855
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rptp-20121231_def.xml EX-101.DEF 367587
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptp-20121231_lab.xml EX-101.LAB 1272677
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptp-20121231_pre.xml EX-101.PRE 595775
Mailing Address 5 HAMILTON LANDING SUITE 160 NOVATO CA 94949
Business Address 5 HAMILTON LANDING SUITE 160 NOVATO CA 94949 415-408-6200
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

EIN.: 860883978 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-KT/A | Act: 34 | File No.: 000-25571 | Film No.: 14833661
SIC: 2834 Pharmaceutical Preparations